APA citiranje

Tam, C. S., Trotman, J., Opat, S., Burger, J. A., Cull, G., Gottlieb, D., . . . Roberts, A. W. (2019). Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL. Blood.

Citação norma Chicago

Tam, Constantine S., et al. "Phase 1 Study of the Selective BTK Inhibitor Zanubrutinib in B-cell Malignancies and Safety and Efficacy Evaluation in CLL." Blood 2019.

MLA citiranje

Tam, Constantine S., et al. "Phase 1 Study of the Selective BTK Inhibitor Zanubrutinib in B-cell Malignancies and Safety and Efficacy Evaluation in CLL." Blood 2019.